(Circulation. 1995;91:2614-2618.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Medicine, The University of Western Ontario, London, Ontario, Canada.
Correspondence to Dr George J. Klein, University Hospital, 339 Windermere Rd, London, Ontario, Canada.
| Abstract |
|---|
|
|
|---|
Methods and Results To examine the implications of this, we identified 36 patients (19 men and 17 women; mean±SD age, 30±13 years) with both phenomena. The 36 patients had 48 accessory pathways. Twenty-seven patients had bidirectional and 9 had unidirectional accessory pathways. Of the 34 patients with inducible atrioventricular reentry, 17 used the slow and 11 used the fast anterograde AV node pathway exclusively during AV reentrant tachycardia, whereas 6 patients used both the fast and the slow AV node pathways. AV node reentrant tachycardia was inducible in addition to AV reentry in 7 patients. Both the cycle length and AH intervals were significantly longer during slow pathwaydependent (cycle length, 411±58 milliseconds [ms]; AH, 229±42 ms) than during fast pathwaydependent (cycle length, 322±40 ms; AH, 121±25 ms; P<.05) reentrant tachycardias. Two patients had only AV node reentrant tachycardia inducible despite the presence of the accessory pathway. Four patients with technically difficult accessory pathways were managed by AV node modification with slow pathway (3) or fast pathway (1) ablation. Three of them remained free of symptoms 7, 14, and 25 months after the procedure whereas 1 patient had recurrence of arrhythmia.
Conclusions AV reentrance with dual AV node pathways frequently depends exclusively on either the slow or the fast AV node pathway for clinical tachycardia. This may provide additional options for ablation in technically difficult cases when the accessory pathway is not otherwise problematic.
Key Words: atrioventricular node physiology tachycardia
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Electrophysiological Study
The study protocol has been
described.12 13
Briefly, standard electrode catheters were positioned in the coronary
sinus, the right ventricular apex, the high right atrium, and at the
His bundle region. Programmed stimulation was performed at twice
diastolic threshold with 2-millisecond (ms) square-wave pulses. Atrial
and ventricular extrastimulus testing at two cycle lengths (600 and 400
ms) was performed until atrial and ventricular refractoriness was
reached. Atrial and ventricular incremental pacing was performed until
AV and ventriculoatrial block occurred, respectively. If reentrant
tachycardia was not inducible with these techniques, burst pacing and
double atrial or ventricular extrastimuli were tried as well as
isoproterenol and atropine administration. After radiofrequency
ablation, the above protocol was repeated 30 minutes after the last
energy application, with extrastimulus testing usually performed at at
least one cycle length (600 ms).
Diagnostic Criteria
The criteria used for the diagnosis of AV
reentry and AV node
reentry have been described.13 Dual AV node pathways
required at least a 50-ms increment in the AH interval for a 10-ms
decrement in coupling interval during atrial extrastimulus testing. AV
node reentrance manifested as either AV node echo cycles or AV node
reentrant tachycardia. When antegrade conduction over the accessory
pathway masked antegrade conduction over the fast AV node pathway, the
diagnosis of dual AV node pathways was based on the test performed
after successful accessory pathway ablation.
Participation of the slow or fast AV node pathway as the antegrade limb of AV reentrant tachycardia was determined by comparison of the AH interval during tachycardia with that observed during slow AV node pathway conduction with atrial extrastimuli, incremental pacing, or AV node reentry. Tachycardia induced by atrial extrastimuli after the discontinuity ("jump") in the AH interval was considered to use the slow AV node pathway for antegrade conduction.
Therapeutic Interventions
Radiofrequency ablation immediately
followed the diagnostic
study. For accessory pathway ablation,14 radiofrequency
current was applied between the 4-mm tip electrode of the ablation
catheter and a backplate. Ablation was not temperature controlled. The
duration of ablation attempts ranged between 10 and 45 seconds. If loss
of preexcitation was not observed during the first 10 seconds of energy
delivery, current was discontinued. AV node modification was performed
using an anatomic approach.15 The operative ablation of
accessory pathways16 and operative AV node
modification17 have been described.
Statistical Analysis
Mean AH intervals and tachycardia cycle
lengths were compared
using Student's t test. Two distinct AH intervals and
tachycardia cycle lengths due to a switch between fast and slow AV node
pathways within an episode of tachycardia were considered as two
distinct tachycardias for statistical purposes.
| Results |
|---|
|
|
|---|
Dual pathway physiology or AV node reentrance was observed before ablation in 24 patients. This diagnosis was made by presence of dual AV node pathways (n=8), alternation of AH intervals during AV reentry (n=6), induction of sustained AV node reentrant tachycardia (n=7), or observation of single AV node reentrant cycles (n=3). The diagnosis was made only after ablation of the accessory pathway in 12 patients. This was manifest as single AV node echo cycles (n=8), dual pathways (n=2), or sustained AV node reentrant tachycardia (n=2).
The most common arrhythmia was AV reentry without coexistent AV node
reentry (27 patients [75%]; Table
). Two (6%)
patients had only AV node reentry, whereas 7 (19%) had both AV reentry
and AV node reentry. Of the 34 patients with AV reentry, 17 used the
slow and 11 used the fast anterograde AV node pathway exclusively,
whereas 6 used both the slow and the fast AV node pathways alternately
(Figs 1
and 2
).
|
|
|
Use of the fast or slow anterograde AV node pathway influenced the
cycle length of AV reentrant tachycardia, and, as expected, this was
related to the AH interval (Figs 3
and 4
). The
cycle length of tachycardia in
patients using the fast AV node pathway anterogradely was shorter than
that in patients using the slow pathway (mean±SD, 322±40 versus
411±58 ms, respectively; P<.001). The AH interval was
shorter in AV reentry using the fast pathway than that using the slow
pathway (121±25 versus 229±42, P<.001).
|
|
Miscellaneous Observations
The coexistence of dual AV node
pathways and AV node reentrance
with AV tachycardia resulted in spontaneous termination of tachycardia
in some patients. This occurred as a result of the occurrence of a
longshort cycle with block in the AV node or accessory pathway of the
subsequent cycle. Alternatively, the occurrence of AV node reentrant
atrial echo cycles sometimes terminated AV reentry (Fig 5
).
|
Accessory pathway bystander participation in AV node reentrant tachycardia was potentially possible in 6 patients where the anterograde refractory period of the accessory pathway permitted accessory pathway conduction at the cycle length of tachycardia. However, this was not observed in any of the study patients, suggesting that this phenomenon is usually limited by concealed retrograde conduction into the accessory pathway.
Therapy
Most patients underwent accessory pathway ablation by
either
catheter14 or surgery.16 One patient had a
failed accessory pathway ablation. Three patients had both
radiofrequency accessory pathway ablation and slow AV node pathway
ablation. Three patients had only slow AV node pathway radiofrequency
ablation. The latter patients had AV reentry dependent on slow AV node
pathway conduction and the accessory pathway was not considered to be
otherwise problematic. None of these patients had inducible arrhythmia
at conclusion of the procedure despite intact accessory pathway
conduction. One patient had multiple tachycardias including AV node
reentry and both antidromic and orthodromic reentry related to two
accessory pathways. Fast AV node pathway ablation done inadvertently
during an attempt at slow pathway ablation was performed and resulted
in noninducibility of tachycardia despite intact accessory pathway
conduction in both directions.
Follow-up
All patients with initially successful accessory
pathway ablation
remain free of tachycardia during a mean follow-up of 21.3 months
(range, 7 to 49 months). Of the 3 patients undergoing slow AV node
pathway ablation, 2 are free of tachycardia after 25 and 7 months, and
1 had recurrence after 14 months. The latter patient was found to have
persistent dual AV node pathways and inducible AV reentrant tachycardia
and subsequently underwent both slow AV node pathway ablation and
accessory pathway ablation. The patient undergoing fast AV node pathway
ablation has not had recurrence of tachycardia and persists with
anterograde preexcitation and anterograde slow AV node pathway
conduction (14 months).
| Discussion |
|---|
|
|
|---|
The observation of two populations of AH intervals during AV reentrant
tachycardia in this study was related to dual AV node pathway
physiology (Figs 1
and 2
). However, alternating
AH intervals may be
observed in the absence of dual pathways,19 20 and
this
may be related to functional oscillation of the AH interval between two
points on the curve relating AH interval to prematurity of atrial
extrastimuli. In the present study, the presence of variable AH
intervals within a given episode of tachycardia contributed to
spontaneous termination of tachycardia in some patients.
The AH interval during AV reentrant tachycardia was found to be a reliable indicator for the presence of anterograde slow or fast AV node pathway conduction. The longest AH interval during tachycardia using the fast AV node pathway was 160 ms, whereas the AH interval was never less than 180 ms in patients using the slow anterograde AV node pathway. These data suggest that an AH interval during AV reentrant tachycardia of longer than 180 ms may raise the suspicion of anterograde slow pathway conduction. The observation also underscores the difficulty of attempting to distinguish AV node reentrant tachycardia from AV reentrant tachycardia by cycle length alone since patients using slow pathway conduction anterogradely may well have cycle lengths similar to patients with typical AV node reentry.
In conclusion, the frequent occurrence of dual AV node pathway conduction underscores the importance of detailed electrophysiological assessment before and after ablation of an accessory pathway. Although there is therapeutic relevance for only a small segment of the total population with the Wolff-Parkinson-White syndrome, alternative ablation strategies directed at the AV node may be considered in individuals when clinical tachycardia depends on either the slow or the fast AV node pathway and the accessory pathway is not otherwise problematic. Appropriate therapy will also be carried out in those presenting with sustained AV node reentry as the exclusive or concomitant clinical arrhythmia. The absence of clinical tachycardia during follow-up in those with only dual pathway physiology with or without single echo cycles would argue against the routine ablation of the slow pathway in these patients.
Received September 29, 1994; revision received December 1, 1994; accepted December 3, 1994.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Pappone, V. Santinelli, F. Manguso, G. Augello, O. Santinelli, G. Vicedomini, S. Gulletta, P. Mazzone, V. Tortoriello, A. Pappone, et al. A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients with the Wolff-Parkinson-White Syndrome N. Engl. J. Med., November 6, 2003; 349(19): 1803 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maury, M. Zimmermann, and J. Metzger Distinction between atrioventricular reciprocating tachycardia and atrioventricular node re-entrant tachycardia in the adult population based on P wave location: Should we reconsider the value of some ECG criteria according to gender and age? Europace, January 1, 2003; 5(1): 57 - 64. [Abstract] [PDF] |
||||
![]() |
B. Belhassen, R. Fish, S. Viskin, A. Glick, M. Glikson, and M. Eldar Adenosine-5'-triphosphate test for the noninvasive diagnosis of concealed accessory pathway J. Am. Coll. Cardiol., September 1, 2000; 36(3): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Chen, C.-E. Chiang, C.-T. Tai, S.-H. Lee, C.-W. Chiou, K.-C. Ueng, Z.-C. Wen, C.-C. Cheng, and M.-S. Chang Longitudinal Clinical and Electrophysiological Assessment of Patients With Symptomatic Wolff-Parkinson-White Syndrome and Atrioventricular Node Reentrant Tachycardia Circulation, June 1, 1996; 93(11): 2023 - 2032. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |